Vanni Bucci, Ph.D. 🇮🇹🇺🇲🇺🇦

Associate Professor Microbiology and Physiological Systems, UMass Chan Medical School. Editor at #GutMicrobes, #mSystems and #MicrobialCell. Florentine

[Rockefeller U. Press @RockUPress]

In @JExpMed, @ReboldiLab @BucciVanni et al. reveal that #microbiome-driven tuft cells’ hyperplasia in the colon helps defend against Clostridioides difficile infection, providing a pathway thru which host & microbial interactions protect against pathogens https://t.co/HeNKUXSxYZ

[Vanni Bucci, Ph.D. 🇮🇹🇺🇲🇺🇦 @BucciVanni]

@mraffatellu Totally agree Manuela!! Thank you!!!

[Vanni Bucci, Ph.D. 🇮🇹🇺🇲🇺🇦 @BucciVanni]

Olive picking at home…#bluezone

[Vanni Bucci, Ph.D. 🇮🇹🇺🇲🇺🇦 @BucciVanni]

@pippograd Thank you Pippo! Solo di passaggio due giorni purtroppo… un abbraccione

[Vanni Bucci, Ph.D. 🇮🇹🇺🇲🇺🇦 @BucciVanni]

@pippograd Sono di Sant’Ilario a Colombaia… grande Pippo!

[Jason Norman @jnormology]

The Vedanta team is very excited to share our latest findings coming out of our successful VE303 Ph2 study in CDI. #IDWeek2024

[Bernat Olle 🇺🇦 @bernatolle]

Vedanta Biosciences To Present at IDWeek 2024 on Benefit of VE303 on Antibiotic Resistant Gene Levels in Patient Microbiomes

https://t.co/IesV7WOGn7

[Vanni Bucci, Ph.D. 🇮🇹🇺🇲🇺🇦 @BucciVanni]

@lingchongyou Amazing work!

[Vanni Bucci, Ph.D. 🇮🇹🇺🇲🇺🇦 @BucciVanni]

Just came back from Memorial
Day at Harvard Bookstore. Will have some fun reads for the next couple of months…

[Front Line Genomics @FLGenomics]

Looking to learn more about the #microbiome? Come along to #FOGBoston and hear from @BucciVanni (Associate Professor, Microbiology and Physiological Systems, @UMassChan). Register now: https://t.co/pEs6HEVaNU

[Prof. Akiko Iwasaki @VirusesImmunity]

TIME's list of the 100 Most Influential People in the world is out. I'm honored, delighted, and grateful to be a part of this incredible group #TIME100 🙏🏼🙏🏼🙏🏼 @TIME
https://t.co/kL0vSNbcmz

[Mick Wallace @wallacemick]

Playing #Juventus is always a difficult game for @TorinoFC_1906 who don't have Juve's money, but the Torino people always have hope - In bocca al Lupo al Toro Sabado - #ForzaToro Sempre...

[Science Magazine @ScienceMagazine]

Early-onset colorectal cancer is expected to become the leading cause of #cancer death in ages 20 to 49 in the U.S. by 2030.

Research is urgently needed to better detect and treat patients, argues this #SciencePerspective: https://t.co/qv8QCDWFs1 #ColorectalCancerAwarenessMonth

[Nature Reviews Microbiology @NatureRevMicro]

Drug-resistant tuberculosis: a persistent global health concern

https://t.co/PQCWhHB3fy

Ahead of #WorldTBDay this weekend, Pai (@paimadhu) & co review the global landscape of drug-resistant TB, its causes, risk factors, impact, latest diagnostics, treatments, and more.

[Vanni Bucci, Ph.D. 🇮🇹🇺🇲🇺🇦 @BucciVanni]

@mitchell_sysbio @MarianaNoto @ScienceMagazine Amazing work Amir and Mariana!!!!

[Mitchell Lab @mitchell_sysbio]

Why are some non-antibiotic drugs toxic to bacteria 💊☠️🦠? Do they work like standard #antibiotics (ABX)? Our latest work by @MarianaNoto published @ScienceMagazine addresses this fundamental question (1/n)
https://t.co/NACiyx8jnz

[Preprint Club - Immunology @preprintclub]

Microbiota time! 🦠 #PreprintHub2 w/ Catherine Shelton @Mari_Byndloss and @AlisaIakupova will discuss a #preprint on how microbial FA metabolism expands tuft cells to protect tissues homeostasis during C. difficile infection @BucciVanni @ReboldiLab 🐭👇

https://t.co/dD72sIUh2M

[Vanni Bucci, Ph.D. 🇮🇹🇺🇲🇺🇦 @BucciVanni]

Microbiota encoded fatty-acid metabolism expands tuft cells to protect tissues homeostasis during Clostridioides difficile infection in the large intestine https://t.co/7AWd4drfWB new preprint from the lab. Finalizing experiments for full paper reviews.. @ReboldiLab

[Science Translational Medicine @ScienceTM]

Commensal bacteria in the gut #microbiome display surprising resilience to #antibiotics, evolve resistance mutations, and reestablish a healthy biome after treatment, shows a 20-month long study of patients with #tuberculosis. @BucciVanni @MichaelGlickma1 https://t.co/rIWW1vYbcE

[Vanni Bucci, Ph.D. 🇮🇹🇺🇲🇺🇦 @BucciVanni]

Our new paper is out! Another great collaboration with @MichaelGlickma1 Commensal antimicrobial resistance mediates microbiome resilience to antibiotic disruption | Science Translational Medicine https://t.co/QJ0U1EwfkI